188 related articles for article (PubMed ID: 12874489)
41. Development and validation of the outburst monitoring scale for children and adolescents.
Kronenberger WG; Giauque AL; Dunn DW
J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):511-26. PubMed ID: 17822345
[TBL] [Abstract][Full Text] [Related]
42. Treatment experiences of children and adolescents with attention-deficit/hyperactivity disorder.
Leggett C; Hotham E
J Paediatr Child Health; 2011 Aug; 47(8):512-7. PubMed ID: 21843188
[TBL] [Abstract][Full Text] [Related]
43. Comorbid symptomatology moderates response to risperidone, stimulant, and parent training in children with severe aggression, disruptive behavior disorder, and attention-deficit/hyperactivity disorder.
Farmer CA; Brown NV; Gadow KD; Arnold LE; Kolko DG; Findling RL; Molina BS; Buchan-Page KA; Rice RR; Bangalore SS; Bukstein O; Rundberg-Rivera EV; McNamara N; Aman MG
J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):213-24. PubMed ID: 25885011
[TBL] [Abstract][Full Text] [Related]
44. Attendance and Engagement in Parent Training Predict Child Behavioral Outcomes in Children Pharmacologically Treated for Attention-Deficit/Hyperactivity Disorder and Severe Aggression.
Joseph HM; Farmer C; Kipp H; Kolko D; Aman M; McGinley J; Arnold LE; Gadow KD; Findling RL; Molina BSG
J Child Adolesc Psychopharmacol; 2019 Mar; 29(2):90-99. PubMed ID: 30592635
[TBL] [Abstract][Full Text] [Related]
45. Attention deficit hyperactivity disorder, combined type: better executive function performance with longer-term psychostimulant medication.
Vance AL; Maruff P; Barnett R
Aust N Z J Psychiatry; 2003 Oct; 37(5):570-6. PubMed ID: 14511085
[TBL] [Abstract][Full Text] [Related]
46. Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy.
Blader JC; Schooler NR; Jensen PS; Pliszka SR; Kafantaris V
Am J Psychiatry; 2009 Dec; 166(12):1392-401. PubMed ID: 19884222
[TBL] [Abstract][Full Text] [Related]
47. What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit/hyperactivity disorder?
Aman MG; Bukstein OG; Gadow KD; Arnold LE; Molina BS; McNamara NK; Rundberg-Rivera EV; Li X; Kipp H; Schneider J; Butter EM; Baker J; Sprafkin J; Rice RR; Bangalore SS; Farmer CA; Austin AB; Buchan-Page KA; Brown NV; Hurt EA; Grondhuis SN; Findling RL
J Am Acad Child Adolesc Psychiatry; 2014 Jan; 53(1):47-60.e1. PubMed ID: 24342385
[TBL] [Abstract][Full Text] [Related]
48. Risperidone Added to Psychostimulant in Children with Severe Aggression and Attention-Deficit/Hyperactivity Disorder: Lack of Effect on Attention and Short-Term Memory.
Farmer CA; Epstein JN; Findling RL; Gadow KD; Arnold LE; Kipp H; Kolko DJ; Butter E; Schneider J; Bukstein OG; McNamara NK; Molina BS; Aman MG
J Child Adolesc Psychopharmacol; 2017 Mar; 27(2):117-124. PubMed ID: 27348211
[TBL] [Abstract][Full Text] [Related]
49. Does collateral retrospective information about childhood attention-deficit/hyperactivity disorder symptoms assist in the diagnosis of attention-deficit/hyperactivity disorder in adults? Findings from a large clinical sample.
Breda V; Rovaris DL; Vitola ES; Mota NR; Blaya-Rocha P; Salgado CA; Victor MM; Picon FA; Karam RG; Silva KL; Rohde LA; Bau CH; Grevet EH
Aust N Z J Psychiatry; 2016 Jun; 50(6):557-65. PubMed ID: 26460329
[TBL] [Abstract][Full Text] [Related]
50. Stimulant-responsive and stimulant-refractory aggressive behavior among children with ADHD.
Blader JC; Pliszka SR; Jensen PS; Schooler NR; Kafantaris V
Pediatrics; 2010 Oct; 126(4):e796-806. PubMed ID: 20837589
[TBL] [Abstract][Full Text] [Related]
51. Participant satisfaction in a study of stimulant, parent training, and risperidone in children with severe physical aggression.
Rundberg-Rivera EV; Townsend LD; Schneider J; Farmer CA; Molina BB; Findling RL; Gadow KD; Bukstein OG; Arnold LE; Kolko DJ; Buchan-Page KA; McNamara NK; Michel C; Austin A; Kipp H; Rice RR; Aman MG
J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):225-33. PubMed ID: 25885012
[TBL] [Abstract][Full Text] [Related]
52. The challenges to demonstrating long-term effects of psychostimulant treatment for attention-deficit/hyperactivity disorder.
Hazell P
Curr Opin Psychiatry; 2011 Jul; 24(4):286-90. PubMed ID: 21519262
[TBL] [Abstract][Full Text] [Related]
53. Risperidone augmentation for treatment-resistant aggression in attention-deficit/hyperactivity disorder: a placebo-controlled pilot study.
Armenteros JL; Lewis JE; Davalos M
J Am Acad Child Adolesc Psychiatry; 2007 May; 46(5):558-565. PubMed ID: 17450046
[TBL] [Abstract][Full Text] [Related]
54. Use of psychostimulant medication for ADHD in South Australia.
Reid R; Hakendorf P; Prosser B
J Am Acad Child Adolesc Psychiatry; 2002 Aug; 41(8):906-13. PubMed ID: 12162626
[TBL] [Abstract][Full Text] [Related]
55. Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.
Snyder R; Turgay A; Aman M; Binder C; Fisman S; Carroll A;
J Am Acad Child Adolesc Psychiatry; 2002 Sep; 41(9):1026-36. PubMed ID: 12218423
[TBL] [Abstract][Full Text] [Related]
56. What is a clinically important level of improvement in symptoms of attention-deficit/hyperactivity disorder?
Hazell P; Lewin T; Sly K
Aust N Z J Psychiatry; 2005 May; 39(5):354-8. PubMed ID: 15860022
[TBL] [Abstract][Full Text] [Related]
57. Lack of effect of stimulant combination with second-generation antipsychotics on weight gain, metabolic changes, prolactin levels, and sedation in youth with clinically relevant aggression or oppositionality.
Penzner JB; Dudas M; Saito E; Olshanskiy V; Parikh UH; Kapoor S; Chekuri R; Gadaleta D; Avedon J; Sheridan EM; Randell J; Malhotra AK; Kane JM; Correll CU
J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):563-73. PubMed ID: 19877981
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of clonidine in the treatment of children with tic disorder co-morbid with attention deficit hyperactivity disorder.
Zeng KD; Wang GL; Yuan Y; Zhang W; Huang XH; Hu B
Eur Rev Med Pharmacol Sci; 2023 May; 27(9):4232-4238. PubMed ID: 37203849
[TBL] [Abstract][Full Text] [Related]
59. Combining methylphenidate and clonidine: a clinically sound medication option.
Wilens TE; Spencer TJ; Swanson JM; Connor DF; Cantwell D
J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):614-9; discussion 619-22. PubMed ID: 10230195
[No Abstract] [Full Text] [Related]
60. Attention deficit hyperactivity disorder: anxiety phenomena in children treated with psychostimulant medication for 6 months or more.
Vance AL; Luk ES; Costin J; Tonge BJ; Pantelis C
Aust N Z J Psychiatry; 1999 Jun; 33(3):399-406. PubMed ID: 10442797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
